Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: A prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency
- 1 June 1997
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 29 (6) , 897-906
- https://doi.org/10.1016/s0272-6386(97)90464-9
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Angiotensin-converting enzyme inhibitors and progression of nondiabetic chronic renal diseaseArchives of internal medicine (1960), 1993
- Long-term comparison between captopril and nifedipine in the progression of renal insufficiencyKidney International, 1992
- Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensivesKidney International, 1990
- A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacksArchives of internal medicine (1960), 1990
- Long-Term Renal Effects of Enalapril Therapy in Patients with Renal InsufficiencyNephron, 1990
- Renal protective effect of strict blood pressure control with enalapril therapyArchives of internal medicine (1960), 1987
- Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunctionArchives of internal medicine (1960), 1986
- Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.Journal of Clinical Investigation, 1986
- Renal Function and Hemodynamics during Treatment with Enalapril in Primary HypertensionNephron, 1986
- Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.Journal of Clinical Investigation, 1985